Regeneron ‘Builds for Growth’ with 150 Hires to Date in Limerick

Regeneron Celebrates First Year in Limerick as Construction of Global Biopharmaceuticals Centre of Excellence Continues

LIMERICK, IRELAND April 27 2015 – Regeneron Pharmaceuticals, Inc., one of the largest and fastest-growing biopharmaceutical companies in the United States, today announced it has hired its 150th employee for its Limerick facility, as it completes its first of a multi-year construction and development programme for the site.

The over $300 million investment in a biopharmaceutical production facility within an 11.88 hectare site at Raheen Business Park, Regeneron’s first facility outside the United States, is on track to commence operations in 2016. In addition to the 150 full-time staff in place already, the site is expected to see employment rise to over 300 people including scientists, engineers, technicians and administrative personnel. Already, 1,200 construction personnel have worked on-site over the course of the past year.

Key milestones in the progress on site to date include:

  • Over 40 Irish companies involved in the project
  • Peak personnel working on the project: 1,200
  • Personnel peak in Raheen during construction in one day: 942 people
  • 1,626,000 accident-free hours of construction on site
  • 60 kilometres of pipe installed and 48,000 tonnes of recycled material reused on site

On Recruitment:

  • Over 150 full-time staff in place
  • 38 percent of current full-time employees from Limerick
  • 76 percent of current full-time employees from Munster
  •  36 percent of the full-time employees studied at the University of Limerick or the Limerick Institute of Technology

Speaking at an event on-site in Limerick to mark the first year of development at the facility, Dan Van Plew, Senior Vice President and General Manager of Industrial Operations and Product Supply (IOPS) at Regeneron, said, “Our approved drugs and robust development pipeline have transformed Regeneron into one of the largest and fastest-growing biopharmaceutical companies in the United States. As our second industrial production site, and the first outside the United States, the Raheen Business Park site will play a prominent role in the future of the company.”

Van Plew continued, “We carefully evaluated a number of locations for our first major international expansion before selecting Limerick, and we have been impressed by the positive, can-do attitude of the local community and IDA Ireland, the expertise provided by NIBRT (National Institute for Bioprocessing Research & Training) and the support we have received at every stage of this process. Thank you for the warmth of your welcome and for making us feel at home here in Limerick.”

For More Please Click:

We use cookies to give you the best online experience. By agreeing you consent the use of cookies in accordance with our Privacy Statement and cookie settings in your Privacy Settings below.

Privacy Settings saved!
Privacy Settings

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie

Decline all Services
Accept all Services